by admin | Jun 26, 2019 | news
Cancer is probably the most sought-after indication in the biopharma world, but it’s missing from 2019’s class of top drug launches. Instead, treatments in immunology and rare genetic diseases have grabbed the limelight. We considered two EvaluatePharma...
by admin | Jun 20, 2019 | news
These aren’t the typical slides you’d see at Endpoints — no molecules, clinical programs, or p-values. Instead, we’ll talk digital and internet trends, factors that elite global brands — regardless of industry — must first measure and understand before deploying...
by admin | Apr 19, 2019 | news
If there’s one law in oncology R&D, it’s that you don’t cross FDA cancer czar Richard Pazdur. Pazdur is famous for cutting companies to shreds during panel reviews if they come to the agency with questionable data after straying from the path he set for...
by admin | Apr 7, 2019 | news
In this analysis, Michael A. Popov, Director Researcher at Prime States Quantum Lab looks at the future trends and applications of the CRISPR Cas9 tool It could be difficult to explain simply why in the last 5 years mathematical cryptography community and community of...
by admin | Apr 2, 2019 | news
New Orleans — New results of a gigantic study testing how well the Apple Watch detects important heart-rhythm changes offer a tantalizing glimpse of how consumer devices might change medicine and lead to new ways to conduct science — but little more. Unfortunately,...
